Metraipolis › archive › dc_4e8f9c765ab9

VK-2019 enhances gemcitabine's antitumor activity in EBV-positive nasopharyngeal carcinoma by upregulating PRODH expression — Europe PMC PMID:42420245

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42420245
DOI
10.1038/s41420-[numero omesso]-z
License (as archived)
solo-consultazione
Archived
2026-10-18T10:01:25.933Z
SHA-256 of the archived text
82db24236eb604ba4e83b4d815f0818059a84df7f9b634398b09784973284e77
Stable URL of this page
https://metraipolis.com/documento/dc_4e8f9c765ab9

How to cite

VK-2019 enhances gemcitabine's antitumor activity in EBV-positive nasopharyngeal carcinoma by upregulating PRODH expression — Europe PMC PMID:42420245 — Europe PMC (en), https://europepmc.org/article/MED/42420245 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4e8f9c765ab9 (Metraipolis archive dc_4e8f9c765ab9, sha256 82db24236eb604ba4e83b4d815f0818059a84df7f9b634398b09784973284e77)
BibTeX
@misc{dc4e8f9c765ab9,
  title = {VK-2019 enhances gemcitabine's antitumor activity in EBV-positive nasopharyngeal carcinoma by upregulating PRODH expression — Europe PMC PMID:42420245},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42420245},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4e8f9c765ab9; sha256 82db24236eb604ba4e83b4d815f0818059a84df7f9b634398b09784973284e77},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42420245. Agents can read the archived copy with the MCP tool read_document.